# RAMELTEON

NDC: 72189-153
Generic name: RAMELTEON
Labeler / Manufacturer: DIRECT RX
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20201103

FDA application: ANDA211567

## Active ingredients

- RAMELTEON: 8 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72189-153"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72189-153
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b336438f-7951-d3b7-e053-2995a90a4d69